natgillin/translations-raw huggingface dataset:
In case of accidental self-injection, seek medical advice immediately and show this package insert or the label to the physician. 
Če vam je bil ta izdelek nenamerno injiciran, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
Poligono Ind. El Montalvo I 
Poligono Ind. El Montalvo I C/Zeppelin 6, Parcela 38
NAME OF THE VETERINARY MEDICINAL PRODUCT Equilis Prequenza Te [a clear pictogram of a horse] 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Equilis Prequenza Te (jasen piktogam konja) KOLIČINA ZDRAVILNE(IH) UČINKOVIN(E)
The vaccine can be used together with Tetanus-Serum from Intervet for treatment of injured horses that have not been immunised against tetanus. 
Cepivo lahko uporabljamo hkrati z Intervetovim Tetanus-Serumom za zdravljenje poškodovanih konj,
6.5 Nature and composition of immediate packaging 
6.5 Vrsta ovojnine in vsebine
A/equine-2/ Newmarket/2/93 
A/konjski-2/ Južna Afrika/4/03 50 AU1 A/konjski-2/ Newmarket/2/93
The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component (see scheme). 
mesecev, ustreznega cepiva proti influenci konj, ki vsebuje seve A/konjski- 2/Južna Afrika/4/03 in A/konjski 2/Newmarket-2/93 (glejte shemo).
Influenza 
Revakcinacija Influenca
QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml: 
KAKOVOSTNA IN KOLIČINSKA SESTAVA
A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE 
A. IZDELOVALEC (IZDELOVALCI) BIOLOŠKE ZDRAVILNE UČINKOVINE (ZDRAVILNIH UČINKOVIN) IN IMETNIK(I) DOVOLJENJ(A) ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROSTITEV SERIJE
THE WORDS "KEEP OUT OF THE REACH AND SIGHT OF CHILDREN" Keep out of the sight and reach of children. 
BESEDILO ''ZDRAVILO SHRANJUJTE NEDOSEGLJIVO OTROKOM Zdravilo shranjujte nedosegljivo otrokom.
QUANTITY OF THE ACTIVE SUBSTANCE(S) 
NAVEDBA ZDRAVILNE(IH) UČINKOVIN(E) IN DRUGIH SESTAVIN(E)
24 months after the first revaccination 
17 mesecev po osnovnem cepljenju 24 mesecev po prvi revakcinaciji
EXPIRY DATE 
DATUM IZTEKA ROKA UPORABNOSTI
C. STATEMENT OF THE MRLs 
C. NAVEDBA NAJVIŠJIH DOVOLJENIH OSTANKOV ZDRAVILA (MRL)
1 ml. 
V odmerku po 1 ml:
CLINICAL PARTICULARS 
FARMACEVTSKA OBLIKA
ANNEX II A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION 
IZDELOVALEC (IZDELOVALCI) BIOLOŠKE ZDRAVILNE UČINKOVINE (ZDRAVILNIH UČINKOVIN) IN IMETNIK(I) DOVOLJENJ(A) ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROSTITEV SERIJE
12 months after the first revaccination 
5 mesecev po osnovnem cepljenju 12 mesecev po prvi revakcinaciji
OTHER INFORMATION 
Dodatek
Phosphatidylcholine 
Fosfatidilholin
Active substances 
Zdravilne učinkovine
None 
Jih ni.
MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration 
(Izmišljeno) ime Jakost
Pack size 
Farmacevtska oblika
Alcohol should be avoided. 
Alkoholu se je treba izogibati.
Other symptoms may include: 
Drugi simptomi lahko vključujejo:
Over 75% of patients were less than 13 years of age. 
Več kot 75 % bolnikov je bilo mlajših od 13 let.
This difference was not statistically significant. 
Razlika ni bila statistično značilna.
The duration of the long-term safety study was limited to 52 weeks. 
Dolgoročna študija varnosti je bila omejena na 52 tednov.
• sudden unexplained death, 
• nenadna nepojasnjena smrt,
Patients should be closely monitored throughout this period. 
Bolnike je treba ves ta čas natančno nadzorovati.
• prolonged and/or painful erection, 
• dolgotrajna in/ali boleča erekcija,
• altered or increased sexual interest; 
• spremenjeno ali povečano spolno zanimanje,
• thoughts of suicide, suicide attempt and suicide, 
• samomorilne misli, poskus samomora in samomor,
These symptoms can temporally deteriorate or can even arise after discontinuation of treatment. 
Takšni simptomi se lahko začasno poslabšajo ali se celo pojavijo po prekinitvi zdravljenja.
If you cannot reach your doctor, go to the nearest hospital and take the pack with you. 
Če ga ne morete dobiti, pojdite v najbližjo bolnišnico in škatlo z zdravilom vzemite s seboj.
Currently available data are described in section 5.1 but no recommendation on a posology can be made. 
Trenutno razpoložljivi podatki so opisani v poglavju 5.1, vendar pa priporočil o odmerjanju ni mogoče dati.
Recurrence prevention was not established. 
Preprečevanja ponovitev niso vrednotili.
Consequently, the frequency of these adverse events is qualified as "not known”. 
Zato je pogostnost teh neželenih učinkov opredeljena kot »neznana«.
Do not use this medicine in children and adolescents under 13 years of age. 
To zdravilo ni namenjeno uporabi pri otrocih in mladostnikih, mlajših od 13 let.
This should be considered in cases where full alertness is required, e.g. when driving a car or handling machines. 
To je treba upoštevati, ko je potrebna popolna zbranost, npr. pri vožnji avtomobila ali upravljanja strojev.
• withdrawal symptoms in newborn babies in case of exposure during pregnancy, 
• odtegnitveni sindromi pri novorojenčkih v primeru izpostavljenosti zdravilu v času nosečnosti,
Some patients may benefit from a higher dose. 
Nekaterim bolnikom lahko koristi večji odmerek.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 30 June 2015 
Datum prve odobritve: 30. Junij 2015 Datum zadnjega podaljšanja:
There are no adequate and well-controlled trials of aripiprazole in pregnant women. 
Ustreznih in dobro kontroliranih preskušanj aripiprazola pri nosečnicah ni.
Caution should be taken, particularly if you are an elderly patient or have some debility. 
Potrebna je previdnost, zlasti če ste starejši ali oslabeli bolnik.
Thus, no dosage adjustment is required for smokers. 
Zato odmerka pri kadilcih ni treba prilagajati.
The maximum daily dose should not exceed 30 mg. 
Največji dnevni odmerek ne sme preseči 30 mg.
The possibility of multiple medicinal product involvement should be considered. 
Upoštevati je treba možnost, da je vpletenih več zdravil.
The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived from spontaneous reports. 
Pogostnosti neželenih učinkov, o katerih so poročali med uporabo v obdobju trženja, ni mogoče določiti, saj je pridobljena iz spontanih poročil.
Adjustments of daily dosage, including dose reduction should be considered on the basis of clinical status. 
O prilagoditvi dnevnega odmerka, vključno z zmanjšanjem odmerka, je treba presoditi na osnovi kliničnega stanja.
It is especially important to mention the following to your doctor: 
Zlasti je pomembno, da svojega zdravnika obvestite, če jemljete naslednja zdravila:
• double vision, 
• dvojni vid,
Increased mortality 
Večja umrljivost
Pharmacokinetics in special patient groups 
Farmakokinetika pri posebnih skupinah bolnikov
• more saliva in mouth than normal, 
• večja količina sline v ustih kot običajno,
No long term data are available with regard to the efficacy and the safety of aripiprazole in this fluctuating disorder. 
Dolgoročni podatki za učinkovitost in varnost aripiprazola pri tej spremenljivi motnji niso na voljo.
Elderly patients with dementia-related psychosis 
Starejši bolniki s psihozo, povezano z demenco
In addition, cases of stroke or "mini" stroke have been reported. 
Poleg tega so poročali tudi o primerih možganske kapi ali "male" kapi.
Due to insufficient safety information in humans and concerns raised by animal reproductive studies, this medicinal product should not be used in pregnancy unless the expected benefit clearly justifies the potential risk to the foetus. 
Zaradi nezadostnih podatkov o varnosti pri človeku in zaradi pomislekov, ki jih porajajo študije razmnoževanja pri živalih, se tega zdravila pri nosečnicah ne sme uporabljati, razen če pričakovana korist nedvomno prevlada nad možnim tveganjem za plod.
Less than 1 % of unchanged aripiprazole was excreted in the urine and approximately 18% was recovered unchanged in the faeces. 
Manj kot 1 % aripiprazola se je nespremenjenega izločilo v urinu in približno 18 % ga je bilo mogoče nespremenjenega najti v blatu.
Patients with rare glucose-galactose malabsorption should not take this medicine. 
Bolniki z redko malabsorpcijo glukoze/galaktoze ne smejo jemati tega zdravila.
Therefore, cardiovascular monitoring should be started immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias. 
Zato je treba takoj uvesti kardiovaskularni nadzor, ki mora vključevati stalno elektrokardiografsko spremljanje za odkritje morebitnih motenj srčnega ritma.
Aripiprazole is effective in a dose range of 10 to 30 mg/day. 
Aripiprazol je učinkovit v razponu odmerkov od 10 do 30 mg/dan.
• difficulty controlling core body temperature or overheating, 
• težave z uravnavanjem jedrne telesne temperature ali pregretje,
• fits (seizures) since your doctor may want to monitor you more closely 
• imate epileptične krče (konvulzije), saj bo zdravnik v tem primeru morda želel natančneje spremljati vaše stanje,
Consequently, newborn infants should be monitored carefully (see section 4.8). 
Posledično je treba takšne novorojenčke skrbno nadzirati (glejte poglavje 4.8).
Animal studies could not exclude potential developmental toxicity (see section 5.3). 
Študije na živalih niso mogle izključiti možnosti toksičnih učinkov na razvoj (glejte poglavje 5.3).
The highest nontumorigenic exposure in female rats was 7 times the human exposure at the recommended dose. 
Največja netumorogena izpostavljenost samic podgan je bila 7- krat večja od izpostavljenosti človeka pri priporočenem odmerku.
The absolute oral bioavailability of the tablet formulation is 87 %. 
Absolutna peroralna biološka uporabnost zdravila v tabletah je 87 %.
• sensitivity to light, 
• občutljivost na svetlobo,
People with this condition may also feel depressed, guilty, anxious or tense. 
Osebe s to boleznijo imajo lahko tudi občutke potrtosti, krivde, tesnobnosti ali napetosti.
Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. 
Obvestite svojega zdravnika, če vi sami ali vaša družina/skrbnik opazite, da se pri vas razvija nagib ali želja po vedenju, ki za vas ni običajno, in se ne morete upreti impulzu, težnji ali skušnjavi po dejanjih, ki bi lahko škodila vam ali drugim.
These trials included patients with or without psychotic features and with or without a rapid-cycling course. 
V ta preskušanja so bili vključeni bolniki s psihotičnimi simptomi ali brez in s hitrim cikličnim potekom ali brez.
It should be noted that impulse-control symptoms can be associated with the underlying disorder; however, in some cases, urges were reported to have stopped when the dose was reduced or the medication was discontinued. 
Upoštevati je treba, da je lahko motnja nadzora impulzov povezana z osnovno boleznijo, vendar so v nekaterih primerih poročali, da so impulzi izzveneli po zmanjšanju odmerka ali ukinitvi zdravila.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/relative should tell your doctor if you have ever had a stroke or "mini" stroke. 
Če ste starejša oseba in imate demenco (slabšanje spomina in drugih duševnih sposobnosti), morate vi ali vaš skrbnik/sorodnik zdravniku povedati, če ste kdaj imeli možgansko kap ali "malo" kap.
During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks. 
Med antipsihotičnim zdravljenjem lahko do izboljšanja bolnikovega kliničnega stanja mine od nekaj dni do več tednov.
• difficulty sleeping, 
• težave s spanjem
If you forget to take your Aripiprazole Mylan Pharma If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day. 
Če ste pozabili vzeti zdravilo Aripiprazol Mylan Pharma Če ste pozabili vzeti odmerek, ga vzemite takoj, ko se spomnite, vendar ne vzemite dveh odmerkov v enem dnevu.
In patients with severe hepatic impairment, the data available are insufficient to establish recommendations. 
Pri bolnikih s hudo okvaro jeter ni dovolj podatkov, da bi lahko oblikovali priporočila.
14 tablets 28 tablets 56 tablets 98 tablets 28 x 1 tablets 
14 tablet 28 tablet 56 tablet 98 tablet 28 x 1 tablet
Doses higher than 10 mg/day should therefore only be used in exceptional cases and with close clinical monitoring (see sections 4.4, 4.8 and 5.1). 
Odmerke, večje od 10 mg/dan je zato treba uporabiti le v izjemnih primerih in ob strogem kliničnem nadzoru (glejte poglavja 4.4, 4.8 in 5.1).
It is not known if it is safe and effective in these patients. 
Varnost in učinkovitost tega zdravila pri teh bolnikih nista znani.
Interaction with receptors other than dopamine and serotonin subtypes may explain some of the other clinical effects of aripiprazole. 
Interakcija z drugimi receptorji razen dopaminskih in serotoninskih podvrst lahko razloži nekatere druge klinične učinke aripiprazola.
Blood pressure-lowering medicines: Aripiprazole Mylan Pharma may increase the effect of medicines used to lower the blood pressure. 
Zdravila za zniževanje krvnega tlaka: zdravilo Aripiprazol Mylan Pharma lahko okrepi učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
Aripiprazole is widely distributed throughout the body with an apparent volume of distribution of 4.9 l/kg, indicating extensive extravascular distribution. 
Aripiprazol se obsežno porazdeli po telesu in ima navidezni volumen porazdelitve 4,9 l/kg, kar kaže na izdatno zunajžilno porazdelitev.
Toxicologically significant effects were observed only at doses or exposures that were sufficiently in excess of the maximum human dose or exposure, indicating that these effects were limited or of no relevance to clinical use. 
Toksikološko pomembne učinke so opazili samo pri odmerkih ali izpostavljenosti, ki je močno presegla največje odmerke ali izpostavljenost pri človeku; to kaže, da so ti učinki za klinično uporabo le omejenega pomena ali celo nepomembni.
Try to take Aripiprazole Mylan Pharma at the same time each day. 
Prizadevajte si vzeti zdravilo Aripiprazol Mylan Pharma vsak dan ob istem času.
Risk factors that may predispose patients to severe complications include obesity and family history of diabetes. 
Med dejavniki tveganja, ki lahko povečajo bolnikovo nagnjenost k hudim zapletom, sta debelost in družinska anamneza diabetesa.
In addition, reports of accidental overdose with aripiprazole alone (up to 195 mg) in children have been received with no fatalities. 
Opisani so tudi primeri naključnega prevelikega odmerjanja aripiprazola samega (do 195 mg) pri otrocih, brez smrtnih primerov.
Pharmacotherapeutic group: Psycholeptics, other antipsychotics, ATC code: N05AX12 
Farmakoterapevtska skupina: psiholeptiki, drugi antipsihotiki, oznaka ATC: N05AX12 Mehanizem delovanja
In subgroup analyses the point estimate of the HR was 0.495 for subjects 13 to 14 years of age compared to 0.454 for subjects 15 to 17 years of age. 
V analizah podskupin je bila izračunana točka razmerja tveganja (HR) 0,495 za bolnike, stare 13 do 14 let, v primerjavi z 0,454 za bolnike, stare 15 do 17 let.
The total body clearance of aripiprazole is 0.7 ml/min/kg, which is primarily hepatic. 
Celotni telesni očistek aripiprazola je 0,7 ml/min/kg in je v prvi vrsti hepatičen.
Caution should be taken when treating patients at higher risk and a lower starting dose should be considered (e.g. elderly or debilitated patients; see section 4.2). 
Pri zdravljenju bolnikov z večjim tveganjem je potrebna previdnost, zato je treba razmisliti o nižjem začetnem odmerku (npr. pri starejših ali oslabljenih bolnikih; glejte poglavje 4.2).
• low levels of white blood cells, 
• nizke ravni belih krvnih celic;
NMS is a potentially fatal symptom complex associated with antipsychotics. 
MNS je potencialno usoden skupek simptomov, povezan z antipsihotiki.
• involuntary, irregular muscle movements, especially in the face 
• imate nehotne, neredne gibe mišic, zlasti na obrazu,
The dose may be gradually increased to the recommended dose for adolescents of 10 mg once a day. 
Odmerek lahko nato postopoma povečuje do priporočenega odmerka za mladostnike, ki je 10 mg enkrat na dan.
• serotonin syndrome (a reaction which may cause feelings of great happiness, drowsiness, 
• serotoninski sindrom (reakcija, ki lahko povzroči močan občutek sreče, omotico, okorelost,
Patients must be advised to notify their physician if they become pregnant or intend to become pregnant during treatment with aripiprazole. 
Bolnicam je treba naročiti, da morajo obvestiti svojega zdravnika, če med zdravljenjem z aripiprazolom zanosijo ali nameravajo zanositi.
The table is based on adverse events reported during clinical trials and/or postmarketing use. 
Preglednica temelji na neželenih učinkih, o katerih so poročali med kliničnimi preskušanji in/ali med uporabo v obdobju trženja.
In a sub-analysis of the adolescent patients between the ages of 15 to 17 years, representing 74 % of the total enrolled population, maintenance of effect was observed over the 26-week open-label extension trial. 
Pri analizi podskupine mladostnikov, starih od 15 do 17 let, ki je obsegala 74 % vseh vključenih bolnikov, se je učinek ohranil ves čas 26-tedenskega odprtega podaljšanega preskušanja.
The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP. 
Načrt za obvladovanje tveganja (RMP) Imetnik dovoljenja za promet z zdravilom bo izvedel zahtevane farmakovigilančne aktivnosti in ukrepe, podrobno opisane v sprejetem RMP, predloženem v modulu 1.8.2 dovoljenja za promet z zdravilom, in vseh nadaljnjih sprejetih posodobitvah RMP.
Schizophrenia in adolescents 
Shizofrenija pri mladostnikih
Since patients treated with antipsychotics often present with acquired risk factors for VTE, all possible risk factors for VTE should be identified before and during treatment with aripiprazole and preventive measures undertaken. 
Ker imajo bolniki, ki se zdravijo z antipsihotiki pogosto pridobljene dejavnike tveganja za VTE, je potrebno pred uvedbo zdravljenja in med zdravljenjem z aripiprazolom identificirati vse možne dejavnike tveganja za VTE in ustrezno preventivno ukrepati.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole Mylan Pharma without first consulting your doctor. 
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila Aripiprazol Mylan Pharma, ne da bi se prej posvetovali z zdravnikom.
Neuroleptic Malignant Syndrome (NMS) 
Maligni nevroleptični sindrom (MNS)
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND 
POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE
While these symptoms can occur at low doses, they occur more frequently and with greater severity with high potency and at higher doses of first generation antipsychotic medicinal products. 
Ti simptomi se sicer lahko pojavijo že pri majhnih odmerkih, vendar pa njihova pogostnost in resnost naraščata z močjo in z uporabo večjih odmerkov antipsihotikov prve generacije.
• yellowing of the skin and white part of eyes, 
• porumenelost kože in očesnih beločnic,
Aripiprazole is extensively metabolised by the liver primarily by three biotransformation pathways: dehydrogenation, hydroxylation, and N-dealkylation. 
Aripiprazol se izdatno presnavlja v jetrih, v prvi vrsti po treh biotransformacijskih poteh: z dehidrogenacijo, hidroksilacijo in N-dealkilacijo.
• past experience with excessive gambling 
• ste kdaj imeli težave s pretiranim hazardiranjem.
• Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached. 
na zahtevo Evropske agencije za zdravila; ob vsakršni spremembi sistema za obvladovanje tveganj, zlasti kadar je tovrstna sprememba posledica prejema novih informacij, ki lahko privedejo do znatne spremembe razmerja med koristmi in tveganji, ali kadar je ta sprememba posledica tega, da je bil dosežen pomemben mejnik (farmakovigilančni ali povezan z zmanjševanjem tveganja).
• blood clots in the veins especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing (if you notice any of these symptoms, seek medical advice immediately), 
• krvni strdki v venah, zlasti v venah nog (simptomi vključujejo oteklino, bolečino in pordelost noge), ki lahko potujejo po krvnih žilah v pljuča in povzročijo bolečino v prsih in težave z dihanjem (če opazite katerega od navedenih simptomov, nemudoma poiščite zdravniško pomoč),
The European Medicines Agency has deferred the obligation to submit the results of studies with aripiprazole in one or more subsets of the paediatric population in the treatment of schizophrenia and in the treatment of bipolar affective disorder (see section 4.2 for information on paediatric use). 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z aripiprazolom za eno ali več podskupin pediatrične populacije pri zdravljenju shizofrenije in bipolarne afektivne motnje (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
The following side effects have been reported since the marketing of oral aripiprazole but the frequency for them to occur is not known: 
O naslednjih neželenih učinkih so poročali v obdobju trženja peroralne oblike aripiprazola; pogostnost pojavljanja le-teh pa ni znana:
Dizziness and vision problems may occur during treatment with this medicine (see section 4). 
Med zdravljenjem s tem zdravilom se lahko pojavijo omotica in težave z vidom (glejte poglavje 4).
Impulse control disorders may result in harm to the patient and others if not recognised. 
Neprepoznane motnje nadzora impulzov lahko vodijo v škodo za bolnika ali druge osebe.
Activated charcoal (50 g), administered one hour after aripiprazole, decreased aripiprazole Cmax by about 41 % and AUC by about 51 %, suggesting that charcoal may be effective in the treatment of overdose. 
Aktivno oglje (50 g), uporabljeno eno uro po aripiprazolu, je zmanjšalo Cmax aripiprazola za približno 41 % in AUC za približno 51 %, kar kaže, da bi bilo oglje lahko učinkovito za zdravljenje prevelikega odmerjanja.
A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from aripiprazole therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman. 
Odločiti se je treba med prenehanjem dojenja in prenehanjem/prekinitvijo zdravljenja z aripiprazolom, pri čemer je treba upoštevati prednosti dojenja za otroka in prednosti zdravljenja za mater.
• accidental inhalation of food with risk of pneumonia (lung infection), 
• naključno vdihanje hrane s tveganjem za pljučnico (okužba pljuč),
• involuntary loss of urine (incontinence), 
• nehoteno uhajanje urina (inkontinenca),
If aripiprazole is administered concomitantly with medicinal products known to cause QT prolongation or electrolyte imbalance, caution should be used. 
Če aripiprazol uporabite sočasno z zdravili, za katera je znano, da podaljšajo interval QT ali povzročajo neravnovesje elektrolitov, morate biti previdni.
Aripiprazole undergoes minimal pre-systemic metabolism. 
Aripiprazol je podvržen minimalni predsistemski presnovi.
• certain antibiotics used to treat tuberculosis (rifabutin, rifampicin) 
• določene antibiotike, ki se uporabljajo za zdravljenje tuberkoloze (rifabutin, rifampicin).
This medicinal product may be started at a low dose with the oral solution (liquid) form. 
Zdravnik lahko predpiše to zdravilo v majhnem začetnem odmerku v obliki peroralne raztopine (tekočine).